Emergent Biosolutions
EBS
EBS
233 hedge funds and large institutions have $2.22B invested in Emergent Biosolutions in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 93 increasing their positions, 86 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
233
Holders Change
-39
Holders Change %
-14.34%
% of All Funds
5.07%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
27
Increased
93
Reduced
86
Closed
61
Calls
$53K
Puts
$43K
Net Calls
+$10K
Net Calls Change
+$223K
Top Buyers
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
$81.7M |
| 2 |
Lazard Asset Management
New York
|
$34.8M |
| 3 |
Jennison Associates
New York
|
$27.2M |
| 4 |
Goldman Sachs
New York
|
$42.5M |
| 5 |
State Street
Boston,
Massachusetts
|
$124M |
